Literature DB >> 26666921

Colistin-Resistant Acinetobacter baumannii Clinical Strains with Deficient Biofilm Formation.

Konstantina Dafopoulou1, Basil Britto Xavier2, An Hotterbeekx2, Lore Janssens2, Christine Lammens2, Emmanuelle Dé3, Herman Goossens2, Athanasios Tsakris4, Surbhi Malhotra-Kumar2, Spyros Pournaras5.   

Abstract

In two pairs of clinical colistin-susceptible/colistin-resistant (Cst(s)/Cst(r)) Acinetobacter baumannii strains, the Cst(r) strains showed significantly decreased biofilm formation in static and dynamic assays (P < 0.001) and lower relative fitness (P < 0.05) compared with those of the Cst(s) counterparts. The whole-genome sequencing comparison of strain pairs identified a mutation converting a stop codon to lysine (*241K) in LpsB (involved in lipopolysaccharide [LPS] synthesis) in one Cst(r) strain and a frameshift mutation in CarO and the loss of a 47,969-bp element containing multiple genes associated with biofilm production in the other.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26666921      PMCID： PMC4776000          DOI： 10.1128/AAC.02518-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  19 in total

1.  Polyphosphate kinase is essential for biofilm development, quorum sensing, and virulence of Pseudomonas aeruginosa.

Authors:  M H Rashid; K Rumbaugh; L Passador; D G Davies; A N Hamood; B H Iglewski; A Kornberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

2.  Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness.

Authors:  Rafael López-Rojas; Michael J McConnell; Manuel Enrique Jiménez-Mejías; Juan Domínguez-Herrera; Felipe Fernández-Cuenca; Jerónimo Pachón
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

3.  Acinetobacter baumannii resistant to colistin with impaired virulence: a case report from France.

Authors:  Jean-Marc Rolain; Antoine Roch; Matthias Castanier; Laurent Papazian; Didier Raoult
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

4.  Proteomic and functional analyses reveal a unique lifestyle for Acinetobacter baumannii biofilms and a key role for histidine metabolism.

Authors:  Maria P Cabral; Nelson C Soares; Jesús Aranda; José R Parreira; Carlos Rumbo; Margarita Poza; Jaione Valle; Valentina Calamia; Iñigo Lasa; Germán Bou
Journal:  J Proteome Res       Date:  2011-06-17       Impact factor: 4.466

5.  Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system.

Authors:  Andrew P Tomaras; Caleb W Dorsey; Richard E Edelmann; Luis A Actis
Journal:  Microbiology       Date:  2003-12       Impact factor: 2.777

6.  Acquisition and role of molybdate in Pseudomonas aeruginosa.

Authors:  Victoria G Pederick; Bart A Eijkelkamp; Miranda P Ween; Stephanie L Begg; James C Paton; Christopher A McDevitt
Journal:  Appl Environ Microbiol       Date:  2014-08-29       Impact factor: 4.792

7.  Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.

Authors:  Jian Li; Roger L Nation; Roxanne J Owen; Stephanie Wong; Denis Spelman; Clare Franklin
Journal:  Clin Infect Dis       Date:  2007-07-17       Impact factor: 9.079

8.  The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective.

Authors:  María Fernández-Reyes; Manuel Rodríguez-Falcón; Cristina Chiva; Jerónimo Pachón; David Andreu; Luis Rivas
Journal:  Proteomics       Date:  2009-03       Impact factor: 3.984

9.  Growth retardation, reduced invasiveness, and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumannii.

Authors:  Spyros Pournaras; Aggeliki Poulou; Konstantina Dafopoulou; Yassine Nait Chabane; Ioulia Kristo; Demosthenes Makris; Julie Hardouin; Pascal Cosette; Athanassios Tsakris; Emmanuelle Dé
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

10.  Employing whole genome mapping for optimal de novo assembly of bacterial genomes.

Authors:  Basil Britto Xavier; Julia Sabirova; Moons Pieter; Jean-Pierre Hernalsteens; Henri de Greve; Herman Goossens; Surbhi Malhotra-Kumar
Journal:  BMC Res Notes       Date:  2014-07-30
View more
  12 in total

1.  Cross-Linked Polymer-Stabilized Nanocomposites for the Treatment of Bacterial Biofilms.

Authors:  Ryan F Landis; Akash Gupta; Yi-Wei Lee; Li-Sheng Wang; Bianka Golba; Brice Couillaud; Roxane Ridolfo; Riddha Das; Vincent M Rotello
Journal:  ACS Nano       Date:  2016-12-27       Impact factor: 15.881

Review 2.  Chromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threat.

Authors:  William Gustavo Lima; Mara Cristina Alves; Waleska Stephanie Cruz; Magna Cristina Paiva
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-03-09       Impact factor: 3.267

Review 3.  Interplay between Colistin Resistance, Virulence and Fitness in Acinetobacter baumannii.

Authors:  Gabriela Jorge Da Silva; Sara Domingues
Journal:  Antibiotics (Basel)       Date:  2017-11-21

4.  Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: analysis of genotype, antimicrobial susceptibility, and biofilm formation.

Authors:  Abbas Bahador; Zahra Farshadzadeh; Reza Raoofian; Masoumeh Mokhtaran; Babak Pourakbari; Maryam Pourhajibagher; Farhad B Hashemi
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-06-01       Impact factor: 3.944

Review 5.  Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments.

Authors:  Emmanuel C Eze; Hafizah Y Chenia; Mohamed E El Zowalaty
Journal:  Infect Drug Resist       Date:  2018-11-15       Impact factor: 4.003

6.  Colistin-resistant Pseudomonas aeruginosa clinical strains with defective biofilm formation.

Authors:  Leila Azimi; Abdolaziz Rastegar Lari
Journal:  GMS Hyg Infect Control       Date:  2019-10-10

7.  Antimicrobial Resistance Mechanisms and Virulence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Taiwan.

Authors:  Noor Andryan Ilsan; Yuarn-Jang Lee; Shu-Chen Kuo; I-Hui Lee; Tzu-Wen Huang
Journal:  Microorganisms       Date:  2021-06-14

8.  Growth Rate and Biofilm Formation Ability of Clinical and Laboratory-Evolved Colistin-Resistant Strains of Acinetobacter baumannii.

Authors:  Zahra Farshadzadeh; Behrouz Taheri; Sara Rahimi; Saeed Shoja; Maryam Pourhajibagher; Mohammad A Haghighi; Abbas Bahador
Journal:  Front Microbiol       Date:  2018-02-12       Impact factor: 5.640

9.  The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.

Authors:  Priya Uppuluri; Lin Lin; Abdullah Alqarihi; Guanpingsheng Luo; Eman G Youssef; Sondus Alkhazraji; Nannette Y Yount; Belal A Ibrahim; Michael Anthony Bolaris; John E Edwards; Marc Swidergall; Scott G Filler; Michael R Yeaman; Ashraf S Ibrahim
Journal:  PLoS Pathog       Date:  2018-05-10       Impact factor: 6.823

10.  A Porcine Wound Model of Acinetobacter baumannii Infection.

Authors:  Daniel V Zurawski; Chad C Black; Yonas A Alamneh; Lionel Biggemann; Jaideep Banerjee; Mitchell G Thompson; Matthew C Wise; Cary L Honnold; Robert K Kim; Chrysanthi Paranavitana; Jonathan P Shearer; Stuart D Tyner; Samandra T Demons
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-01-05       Impact factor: 4.730
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.